Online pharmacy Netmeds acquired the medicine delivery app for an undisclosed sum, providing an exit for Pluss backer IDG Ventures India.

Chiesi Farmaceutici has agreed to acquire Atopix Therapeutics, an indirect spinout of Oxford University, in a transaction potentially worth in excess of $80m.

Chiesi Farmaceutici has agreed to acquire Atopix Therapeutics, an indirect spinout of Oxford University, in a transaction potentially worth in excess of $80m.

A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.

WuXi AppTec was among the investors in a series A-1 round that increased the GV-backed life sciences researcher's total funding to $27m.

The monoclonal antibody developer took its total funding to about $220m since 2010 in a round that included Shenzhen Hepalink and Malin Corporation.

The UK-based pharmaceuticals company joins an investor group that includes Biogen, GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer and Takeda.

The coronary stent technology developer, backed by GE and St Jude Medical, has raised $25.8m in a round expected to close at $30m.

Existing backers Novartis and LabCorp came back for blood collection system developer Seventh Sense Biosystems' series C round having previously invested in 2014.